Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.58 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.58 |
| ▸ | MAOB | P27338 | 4/20 | 0.47 |
| ▸ | MAOA | P21397 | 2/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.47 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA3 | P07451 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | IDO1 | P14902 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.42 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9552723 | 0.93 | LOXL2 (0.52) | LOXL2CYP2A6MAOBMAOACYP19A1 | |
| SCHEMBL9553015 | 0.93 | LOXL2 (0.52) | LOXL2CYP2A6MAOBMAOACYP19A1 | |
| SCHEMBL9553356 | 0.93 | LOXL2 (0.52) | LOXL2CYP2A6MAOBMAOACYP19A1 | |
| SCHEMBL12229945 | 0.84 | CYP2A6 (0.48) | LOXL2CYP2A6MAOBMAOACYP19A1 | |
| SCHEMBL2517860 | 0.84 | LSS (0.47) | LOXL2CYP2A6MAOBMAOACYP19A1 | |
| SCHEMBL14764212 | 0.80 | LOXL2 (0.60) | LOXL2CYP2A6MAOBMAOACYP19A1 | |
| SCHEMBL1004267 | 0.78 | LOXL2 (0.64) | LOXL2CYP2A6MAOBMAOACYP19A1 | |
| SCHEMBL1344068 | 0.78 | LOXL2 (0.65) | LOXL2CYP2A6MAOBMAOACYP19A1 | |
| SCHEMBL45942 | 0.76 | CA2 (0.69) | LOXL2CYP2A6MAOBMAOAALDH1A1 | |
| SCHEMBL2503454 | 0.76 | CA2 (0.69) | LOXL2CYP2A6MAOBMAOAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119462506-A | Long-chain ketonitrile compound and preparation method and application thereof | 华东理工大学 | 2025-02-18 | — | — | CN | disclosed |
| CN-118932350-A | Method for synthesizing carboxylic acid and deuterated carboxylic acid compound through electrochemical defluorination | 江西师范大学 | 2024-11-12 | — | — | CN | disclosed |
| CN-117106003-A | Preparation method of organic fluorine compound | 浙江工业大学 | 2023-11-24 | — | — | CN | disclosed |
| CN-114105722-B | Method for preparing organic fluorine compound | 浙江工业大学 | 2023-10-20 | — | — | CN | disclosed |
| CN-114105722-A | Method for preparing organic fluorine compound | 浙江工业大学 | 2022-03-01 | — | — | CN | disclosed |
| US-20210155561-A1 | METHOD AND REAGENT FOR DEOXYFLUORINATION | SOUTH DAKOTA BOARD OF REGENTS (US) | 2021-05-27 | — | — | US | disclosed |
| US-20210155561-A1 | METHOD AND REAGENT FOR DEOXYFLUORINATION | SOUTH DAKOTA BOARD OF REGENTS (US) | 2021-05-27 | — | — | US | disclosed |
| WO-2020037109-A1 | PROCESSES FOR FLUORINATION | DOW AGROSCIENCES LLC (US) | 2020-02-20 | — | — | WO | disclosed |
| CN-110506040-A | Kill the oxadiazole derivatives of microorganism | SYNGENTA PARTICIPATIONS AG | 2019-11-26 | — | — | CN | disclosed |
| CN-106573927-B | Oxyclohepten-2-yl-pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use | 豪夫迈·罗氏有限公司 | 2019-09-27 | — | — | CN | disclosed |
| CN-105658628-A | Novel arylalkene derivatives and use thereof as selective estrogen receptor modulators | 北京赛林泰医药技术有限公司 | 2016-06-08 | — | — | CN | disclosed |
| CN-105283439-A | BORON-CONTAINING DIACYLHYDRAZINES | INTREXON CORP | 2016-01-27 | — | — | CN | disclosed |
| CN-104640858-A | Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use | HOFFMANN LA ROCHE | 2015-05-20 | — | — | CN | disclosed |
| CN-102209717-B | Compounds for the treatment of hepatitis c | BRISTOL MYERS SQUIBB CO | 2015-02-18 | — | — | CN | disclosed |
| CN-104080771-A | Apoptosis signal-regulating kinase inhibitors | GILEAD SCIENCES INC | 2014-10-01 | — | — | CN | disclosed |
| CN-103261167-A | Substituted 6,6-used nitrogenous heterocyclic compounds and uses thereof | HOFFMANN LA ROCHE | 2013-08-21 | — | — | CN | disclosed |
| EP-2137188-B1 | SUBSTITUTED IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES | Bayer Pharma AG (DE) | 2012-06-06 | — | — | EP | disclosed |
| EP-1465880-B1 | 5-SULPHANYL-4H-1,2,4-TRIAZOLE DERIVATIVES AND THEIR USE TO TREAT DISORDERS ASSOCIATED WITH SOMATOSTATINE | IPSEN PHARMA (FR) | 2009-08-05 | — | — | EP | disclosed |
| EP-1467974-B1 | BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS GNRH ANTAGONISTS | SOD CONSEILS RECH APPLIC (FR) | 2007-08-15 | — | — | EP | disclosed |
| US-4051168-A | TO FORM FLUOROALKYL AROMATIC COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210155561-A1 | METHOD AND REAGENT FOR DEOXYFLUORINATION | PFAS, FIBP, NPFFR2 | LOXL2 3429/4885CYP2A6 2204/4885MAOB 844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.